Sun Advantage Savings and Investment Planhttps://pcaobus.org/form-ap-filings/58948/58948Sun Advantage Savings and Investment Plan589487/16/2020 5:49:57 PM2019926505cb-e0d1-4bce-83f7-aac5bc6d253e34Deloitte & Touche LLP123634Sun Advantage Savings and Investment Plan1097362SLF; SLF.; SLFYF; SLF.PR.A; SLF.PR.B; SLF.PR.C; SLF.PR.D; SNLFF; SLF.PR.E; SLF.PR.F; SUNFF; SLF.PR.G; SLF.PR.H; SLFXF; SLF.PR.I; SLF.PR.J; SLF.PR.K0003411293Christopher Conrad Smith00034112931208Deloitte LLP (French Translation: Deloitte S.E.N.C.R.L./s.r.l.)True
EyePoint Pharmaceuticals, Inc.https://pcaobus.org/form-ap-filings/55163/55163EyePoint Pharmaceuticals, Inc.551634/14/2020 10:20:09 PM20198bd645c6-f48b-4d60-9424-e4a693cc5e6234Deloitte & Touche LLP706216EyePoint Pharmaceuticals, Inc.1314102EYPT0003411293Christopher Conrad Smith0003411293True
Minerva Neurosciences, Inc.https://pcaobus.org/form-ap-filings/54155/54155Minerva Neurosciences, Inc.541554/2/2020 5:32:04 PM2019923eda7d-529f-4f6e-8940-9682bac6f78034Deloitte & Touche LLP579539Minerva Neurosciences, Inc.1598646NERV0003411293Christopher Conrad Smith0003411293True
Apellis Pharmaceuticals, Inc.https://pcaobus.org/form-ap-filings/51389/51389Apellis Pharmaceuticals, Inc.513893/12/2020 11:24:22 PM2019ca3079cd-679c-4da3-ad1a-afaeb69cec3834Deloitte & Touche LLP478660Apellis Pharmaceuticals, Inc.1492422APLS0003411293Christopher Conrad Smith0003411293True
Sun Advantage Savings and Investment Planhttps://pcaobus.org/form-ap-filings/43933/43933Sun Advantage Savings and Investment Plan439337/10/2019 8:10:16 PM2018a27a2eab-f908-4a6c-aebc-6ef01a6e8da434Deloitte & Touche LLP123634Sun Advantage Savings and Investment Plan1097362SLF; SLF.; SLFYF; SLF.PR.A; SLF.PR.B; SLF.PR.C; SLF.PR.D; SNLFF; SLF.PR.E; SLF.PR.F; SUNFF; SLF.PR.G; SLF.PR.H; SLFXF; SLF.PR.I; SLF.PR.J; SLF.PR.K0003411293Christopher Conrad Smith0003411293True
EyePoint Pharmaceuticals, Inc.https://pcaobus.org/form-ap-filings/39234/39234EyePoint Pharmaceuticals, Inc.392344/16/2019 10:08:40 PM2018d1830578-3335-4362-b281-db120863c9f534Deloitte & Touche LLP706216EyePoint Pharmaceuticals, Inc.1314102EYPT0003411293Christopher Conrad Smith0003411293True
Minerva Neurosciences, Inc.https://pcaobus.org/form-ap-filings/36384/36384Minerva Neurosciences, Inc.363843/23/2019 2:01:36 PM2018d0d70c0f-6e41-45a1-bb0a-dc5eb5a7e82b34Deloitte & Touche LLP579539Minerva Neurosciences, Inc.1598646NERV0003411293Christopher Conrad Smith0003411293True
EyePoint Pharmaceuticals, Inc.https://pcaobus.org/form-ap-filings/30062/30062EyePoint Pharmaceuticals, Inc.3006210/16/2018 4:33:54 PM20182a69dbe6-c953-4867-885a-3fa370b428d834Deloitte & Touche LLP706216EyePoint Pharmaceuticals, Inc.1314102EYPT0003411293Christopher Conrad Smith0003411293True
Minerva Neurosciences, Inc.https://pcaobus.org/form-ap-filings/20524/20524Minerva Neurosciences, Inc.205243/26/2018 7:41:52 PM2017534a8bca-051e-49b9-824f-fa08a705400a34Deloitte & Touche LLP579539Minerva Neurosciences, Inc.1598646NERV0003411293Christopher Conrad Smith0003411293True
Dicerna Pharmaceuticals Inchttps://pcaobus.org/form-ap-filings/6543/6543Dicerna Pharmaceuticals Inc65434/21/2017 4:11:51 PM20166b8ea913-2177-43ad-b56e-2d774f15c32134Deloitte & Touche LLP387859Dicerna Pharmaceuticals Inc1399529DRNA0003411293Christopher Conrad Smith0003411293True